Through
4/26
A Penn Medicine-led trial found medications to be neither beneficial or harmful in the treatment of hospitalized patients.
Penn neuroscientists are developing innovative ways to treat neurological diseases, including implanting neural tissue like a brain organoid to rebuild brain circuitry.
Increasing rates of food insecurity in counties across the United States are independently associated with an increase in cardiovascular death rates among adults between the ages of 20 and 64.
A first-of-its-kind Penn Medicine study paints a detailed picture of the heart’s fuel and nutrient use.
A team led by scientists in the Perelman School of Medicine has engineered powerful new antimicrobial molecules from toxic proteins found in wasp venom.
An analysis led by Penn Medicine identifies gender disparities in authorship of heart failure guideline citations and clinical trials.
An Enhanced Recovery After Surgery protocol for elective spine and peripheral nerve surgery decreases opioid use and the length of hospital stays.
A variety of research efforts across Penn are working to uncover the neurological implications of COVID-19, including stroke, neuroinflammation, and loss of smell.
A discovery by Penn researchers in siblings may hold answers to new gene therapies for Charcot-Marie-Tooth disease.
While researchers found that 2.4% of patients hospitalized for COVID-19 had an ischemic stroke—the most common type of stroke, a new study suggests this is likely due to existing risk factors, rather than COVID-19.